Pfizer and BioNTech provide update on Omicron variant
- Details
- Category: Pfizer

Roche completed the repurchase of Roche shares from Novartis
- Details
- Category: Roche

GSK and the University of Oxford launch new Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease
- Details
- Category: GlaxoSmithKline

AWS helps Pfizer accelerate drug development and clinical manufacturing
- Details
- Category: Pfizer

GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community
- Details
- Category: GlaxoSmithKline

Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipeline
- Details
- Category: Sanofi

Pfizer and BioNTech receive expanded U.S. FDA emergency use suthorization of COVID-19 vaccine booster to include individuals 18 and older
- Details
- Category: Business

More Pharma News ...
- GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment
- Pfizer to provide U.S. government with 10 million treatment courses of investigational oral antiviral candidate to help combat COVID-19
- Two billion doses of AstraZeneca’s COVID-19 vaccine supplied to countries across the world
- Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
- Merck and Ridgeback's molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world
- Johnson & Johnson COVID-19 vaccine named one of Time's Best Inventions of 2021
- CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease